{"id":"W2149388786","doi":"10.1056/nejmoa1007432","title":"Apixaban in Patients with Atrial Fibrillation","year":2011,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":2420,"is_retracted":false,"has_abstract":true,"ca_institutions":"Population Health Research Institute","funders":"Bayer Vital; St. Jude Medical; Cilag; Astellas Pharma; Sanofi; Hamilton Health Sciences; GlaxoSmithKline; Institut de Cardiologie de Montréal; Servier; McMaster University; Pfizer; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Atrial fibrillation; Apixaban; Cardiology; Internal medicine; Medicine; Warfarin; Rivaroxaban","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001393069,0.0002807337,0.000970014,0.0003841419,0.0004882402,0.0006063305,0.0002257364,0.0007468396,0.002274428],"category_scores_gemma":[0.004632549,0.0001778725,0.0006314841,0.0008787681,0.00033101,0.0003574656,0.0002684038,0.001197255,0.0003889826],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002781863,"about_ca_system_score_gemma":0.0005685309,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004412456,"about_ca_topic_score_gemma":0.0004087003,"domain_scores_codex":[0.9988744,0.000459678,0.0001716792,0.0001359092,0.0002565942,0.000101708],"domain_scores_gemma":[0.9979831,0.0007105896,0.000786925,0.00009781464,0.0001244654,0.0002970048],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.02070844,0.0009474633,0.8436179,0.001224672,0.0007216295,0.003075925,0.0002985429,0.0004114498,0.001893599,0.0005316238,0.006133053,0.1204356],"study_design_scores_gemma":[0.01170016,0.01362706,0.9260715,0.0009241776,0.001821992,0.01700323,0.0003562337,0.001889334,0.001210203,0.002136397,0.02320642,0.00005323562],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9225093,0.06008701,0.0009682949,0.004719337,0.0007829655,0.0003322533,0.0006169319,0.00004284244,0.00994115],"genre_scores_gemma":[0.9886593,0.007767546,0.0004280488,0.00152527,0.000758681,0.0001283642,0.0003940126,0.0000040269,0.0003348174],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002274428,"threshold_uncertainty_score":0.007608712,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04872069212477084,"score_gpt":0.2871827491352683,"score_spread":0.2384620570104975,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}